Peter K Jarrett

USPTO Granted Patents = 29 (Patent Applications = 23)

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 19)

Average Co-Inventor Count = 4.8

ph-index = 12

Forward Citations = 413(Granted Patents)

Location History:

Sudbury, MA (US) (2006 - 2015)
Lexington, MA (US) (2013 - 2024)
Burlington, MA (US) (2022 - 2024)

Company Filing History:

Ocular Therapeutix, Inc.

4. 1 out of 832,680

Other

patents

Years Active: 2006-2025

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12453724 - Ocular implant containing a tyrosine kinase inhibitor (2025-10-28),

2. 12357565 - Ocular implant containing a tyrosine kinase inhibitor (2025-07-15),

3. 12226341 - Implant injector device (2025-02-18),

4. 12171869 - Intracameral drug delivery depots (2024-12-24),

5. 12161753 - Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent (2024-12-10),

6. 12109302 - Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine (2024-10-08),

7. 12023276 - Intracanalicular depot inserter device (2024-07-02),

8. 11938223 - Shape changing drug delivery devices and methods (2024-03-26),

9. 11890343 - Medical organogel processes and compositions (2024-02-06),

10. 11779536 - Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine (2023-10-10),

11. 11534396 - Methods of treatment with an ocular implant containing a tyrosine kinase inhibitor (2022-12-27),

12. 11439592 - Ocular implant containing a tyrosine kinase inhibitor (2022-09-13),

13. 11413250 - Shape changing drug delivery devices and methods (2022-08-16),

14. 11369591 - Drug delivery from hydrogels (2022-06-28),

15. 11331267 - Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine (2022-05-17),

Title: Peter K. Jarrett: A Pioneer in Ocular Innovations

Introduction

Peter K. Jarrett, a prolific inventor based in Sudbury, MA, holds an impressive portfolio of 27 patents. His work primarily focuses on innovative technologies for ocular treatments and delivery systems, significantly impacting the field of eye care.

Latest Patents

Among his latest inventions is the Implant Injector Device, which features a dual assembly system designed for precise implantation. The first assembly houses a plunger mechanism, while the second assembly integrates a needle that facilitates the secure delivery of an implant. This innovative design underscores the importance of safety and efficiency in medical applications.

Another significant patent is the Intracameral Drug Delivery Depots. This method involves placing a composite depot containing a xerogel with embedded degradable particles in the anterior chamber of the eye. The xerogel transitions into a hydrogel upon exposure to intraocular fluid, allowing for the controlled release of therapeutic agents, which is crucial in treating various ocular conditions.

Career Highlights

Peter has worked with several notable companies, including Incept, LLC and Ocular Therapeutix, Inc. His experience in these organizations has allowed him to contribute to the development of cutting-edge ocular therapies. His 27 patents reflect his commitment to advancing medical technology, especially in the field of ophthalmology.

Collaborations

Throughout his career, Peter has collaborated with talented individuals in his field. Notable among them are Rami El-Hayek and Amarpreet S. Sawhney, who have played pivotal roles in his projects, enhancing the scope and applicability of his inventions.

Conclusion

Peter K. Jarrett's contributions to ocular innovations are marked by his 27 patents, reflecting his dedication to improving eye care technologies. His pioneering work, in collaboration with esteemed colleagues and companies, continues to shape the future of ocular treatments, providing enhanced solutions for various eye conditions.

This text is generated by artificial intelligence and may not be accurate.